nach oben

Endocrine

Erschienen in:

04.08.2020 | COVID-19 | Viewpoint Zur Zeit gratis

Thyroid cancer in the Era of COVID-19

verfasst von: Anabella Smulever, Erika Abelleira, Fernanda Bueno, Fabián Pitoia

Erschienen in: Endocrine | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

The recent coronavirus infectious disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is placing health systems in serious challenges worldwide. Shocking statistics each day has prompted the World Health Organization to officially declare the COVID-19 outbreak as a pandemic in March 2020. Preliminary studies have shown increased mortality in patients with solid cancers and infection by SARS-CoV-2. Until now, the evidence on the behavior of COVID-19 in patients with a history of thyroid cancer remains scarce, and most of the recommendations given are based on common sense. Therefore, in this viewpoint, we present a brief review of several challenges we are frequently facing during this pandemic and a series of recommendations based on what we have implemented in our clinical practice at a university hospital currently mostly dedicated to COVID-19.

B. Diao, C. Wang, Y. Tan, X. Chen, Y. Liu, L. Ning, L. Chen, M. Li, Y. Liu, G. Wang, Z. Yuan, Z. Feng, Y. Zhang, Y. Wu, Y. Chen, Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front. Immunol. 11, 827 (2020)CrossRef

R. Channappanavar, S. Perlman, Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 39, 529–539 (2017)CrossRef

N.M. Kuderer, T.K. Choueiri, D.P. Shah, Y. Shyr, S.M. Rubinstein, D.R. Rivera, S. Shete, C.Y. Hsu, A. Desai, G. de Lima Lopes Jr, P. Grivas, C.A. Painter, S. Peters, M.A. Thompson, Z. Bakouny, G. Batist, T. Bekaii-Saab, M.A. Bilen, N. Bouganim, M. Bover Larroya, D. Castellano, S.A. Del Prete, D.B. Doroshow, EganP.C. Elkrief, A. Dimitrios Farmakiotis, D. Flora, M.D. Galsky, M.J. Glover, M.A. Griffiths, A.P. Gulati, S. Gupta, N. Hafez, T.R. Halfdanarson, J.E. Hawley, E. Hsu, A. Kasi, A.R. Khaki, C.A. Lemmon, C. Lewis, B. Logan, T. Masters, R.R. McKay, R.A. Mesa, A.K. Morgans, M.F. Mulcahy, O.A. Panagiotou, P. Peddi, N.A. Pennell, K. Reynolds, L.R. Rosen, R. Rosovsky, M. Salazar, A. Schmidt, S.A. Shah, J.A. Shaya, J. Steinharter, K.E. Stockerl-Goldstein, S. Subbiah, D.C. Vinhv, F.H. Wehbe, L.B. Weissmann, J. Tsu-Yu Wu, E. Wulff-Burchfield, Z. Xie, A. Yeh, P.P. Yu, A.I. Zhou, L. Zubiri, S. Mishra, G.H. Lyman, B.I. Rini, J.L. Warner, on behalf of the COVID-19 and Cancer Consortium: clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395, 1907–1918 (2020)CrossRef

M.C. Garassino, J.G. Whisenant, L.C. Huang, A. Trama, V. Torri, F. Agustoni, J. Baena, G. Banna, R. Berardi, A.C. Bettini, E. Bria, M. Brighenti, J. Cadranel, A. De Toma, C. Chini, A. Cortellini, E. Felip, G. Finocchiaro, P. Garrido, C. Genova, R. Giusti, V. Gregorc, F. Grossi, F. Grosso, S. Intagliata, N. La Verde, S.V. Liu, J. Mazieres, E. Mercadante, O. Michielin, G. Minuti, D. Moro-Sibilot, G. Pasello, A. Passaro, V. Scotti, P. Solli, E. Stroppa, M. Tiseo, G. Viscardi, L. Voltolini, Y.L. Wu, S. Zai, V. Pancaldi, A.M. Dingemans, J. Van Meerbeeck, F. Barlesi, H. Wakelee, S. Peters, L. Horn, on behalf of the TERAVOLT investigators: COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2045, 30314–30314 (2020)

M.M. Montesinos, C.G. Pellizas, Thyroid hormone action on innate immunity. Front. Endocrinol. 10(350), 1–9 (2019)

E.L. Jara, N. Muñoz-Durango, C. Llanos, C. Fardella, P.A. González, S.M. Bueno, A.M. Kalergis, C.A. Riedel, Modulating the function of the immune system by thyroid hormones and thyrotropin. Immunol. Lett. 184, 76–83 (2017)CrossRef

S.P. Umland, R.P. Schleimer, S.L. Johnston, Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm. Pharmacol. Ther. 15, 35–50 (2002)CrossRef

I.J. Elenkov, R.L. Wilder, G.P. Chrousos, E.S. Vizi, The sympathetic nerveean integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595–638 (2000)PubMed

T.K. Eisenstein, M.E. Hilburger, Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83, 36–44 (1998)CrossRef

10.

D. Dworakowska, A.B. Grossman, Thyroid disease in the time of COVID-19. Endocrine. 68, 471–474 (2020)CrossRef

11.

B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 26, 1–133 (2016)CrossRef

12.

A. Tofani, R. Sciuto, R.P. Cioffi, R. Pasqualoni, S. Rea, A. Festa, G.M. Gandolfo, M.C. Arista, C.L. Maini, Radioiodine-induced changes in lymphocyte subsets in patients with differentiated thyroid carcinoma. Eur. J. Nucl. Med. 26, 824–829 (1999)CrossRef

13.

V. Barsegian, S.P. Müller, P.A. Horn, A. Bockisch, A. Lindemann, Lymphocyte function following radioiodine therapy in patients with thyroid carcinoma. Nuklearmedizin. 50, 195–203 (2011)CrossRef

14.

F. Pitoia, F. Jerkovich, Dynamic risk assessment in patients with differentiated thyroid cancer. Endocr Relat Cancer 26, 553–566 (2019)CrossRef

15.

E. Robenshtok, S. Fish, A. Bach, J.M. Domínguez, A. Shaha, R.M. Tuttle, Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J. Clin. Endocrinol. Metab. 97, 2706–2713 (2012)CrossRef

16.

F.A.B. Schutz, Y. Je, T.K. Choueiri, Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: a meta-analysis of clinical trials. Crit. Rev. Oncol. Hematol. 80, 291–300 (2011)CrossRef

17.

L. Goyal, H. Zheng, M.B. Yurgelun, T.A. Abrams, J.N. Allen, J.M. Cleary, M. Knowles, E. Regan, A. Reardon, A. Khachatryan, R.K. Jain, V. Nardi, D.R. Borger, D.G. Duda, A.X. Zhu, A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma. Cancer. 123, 1979–1988 (2017)CrossRef

18.

S. Nakamichi, H. Nokihara, N. Yamamoto, Y. Yamada, K. Honda, Y. Tamura, H. Wakui, T. Sasaki, W. Yusa, K. Fujino, T. Tamura, A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors. Cancer Chemother. Pharmacol. 76, 1153–1161 (2015)CrossRef

19.

A.R. Filippi, E. Russi, S.M. Magrini, R. Corvò, Covid-19 outbreak In Northern Italy: first practical indications for radiotherapy departments. Int. J. Radiat. Oncol. Biol. Phys. 107(3), 597–599 (2020)CrossRef

Titel: Thyroid cancer in the Era of COVID-19
verfasst von: Anabella Smulever
Erika Abelleira
Fernanda Bueno
Fabián Pitoia
Publikationsdatum: 04.08.2020
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Endocrine / Ausgabe 1/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-020-02439-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Circulating vitamin D and the risk of gestational diabetes: a systematic review and dose-response meta-analysis

A non-surgical approach to 46,XY differences in sex development through hormonal suppression at puberty: a single-center case series study

Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database

Impact of short-term hydrocortisone intake on pituitary and adrenal function in healthy young male subjects

Τriglycerides-glucose (TyG) index is a sensitive marker of insulin resistance in Greek children and adolescents

Sleep apnea in men is associated with altered lipid metabolism, glucose tolerance, insulin sensitivity, and body fat percentage